Position in GALT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,070,947
+$4,361,275 QoQ
Shares Held
1,308,394
+113.5% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. GALT ranks #227 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in GALT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,070,947 | 1,308,394 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,709,672 | 612,786 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,487,986 | 598,074 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,684,203 | 633,067 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,405,662 | 666,191 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,040,300 | 852,706 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,123,059 | 870,589 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,371,990 | 862,542 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,902,298 | 841,725 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,355,514 | 567,161 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $853,930 | 514,416 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $980,027 | 510,431 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $752,091 | 522,286 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,095,523 | 521,678 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $580,610 | 513,815 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $837,660 | 513,902 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $669,592 | 511,139 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $898,766 | 558,240 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,158,636 | 559,728 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,098,560 | 540,866 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,308,841 | 409,013 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,401,531 | 645,867 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,438,312 | 642,104 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,587,638 | 594,621 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,816,722 | 593,700 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,100,281 | 561,368 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||